Gene therapy pioneer Jim Wilson and researcher Kiran Musunuru are using contrasting approaches to overcome “irrational ...
A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Avalo Therapeutics (AVTX – Research Report) and ...
Biotech is an area that may offer your portfolio growth today and earnings stability tomorrow. The idea is a biotech stock ...
Reuters reported that President Trump’s tariffs have impacted the broader stock markets, weighing on investors’ sentiments, ...
1d
Zacks Investment Research on MSNCRISPR Therapeutics Stock Trades Near 52-Week Low: Time to Buy or Sell?Shares of CRISPR Therapeutics CRSP closed at $40.97 on Tuesday, close to their 52-week low of $36.52. This decline in CRSP ...
We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on wallstreetbets Subreddit Page by MADD-Scientis. In this ...
Targeted CRISPR lipid nanoparticles eliminated 50% of tumors in mice with head and neck cancer.
We recently published a list of Ark Invest Stock Portfolio: Top 10 Stocks to Buy. In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against other top ...
Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...
The gene therapy world is in turmoil, but Arbor, armed with more than a billion dollars in partnerships and raises, is going forward.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results